INTRODUCTION
Infertility is a condition in women's life which indicates inability to procreate. Conception depends on multiple factors, ovulation being one among them. A remarkable decline in human fertility is observed beyond the age of 30 years due to reduction in quality and number of healthy ovum. Anovulation is reported to be one of the major cause for female infertility ranging up to 25 -40% of infertile women.
[1] If the menstrual cycles followed by ovulation are related to an outside influence like nutrition or lifestyle, effective treatments will include regulating eating habits and moderating physical activities. Making changes to one's weight (gaining or losing weight) may also be enough to jump-start stalled ovulation. Sometimes internal imbalances are the reason and in such cases, medications are to be prescribed for fertility. These medications are designed to combat the cause of a woman's infertility. There are drugs designed to ripen the follicles, increase estrogen and help the ovaries release an egg.
[2]
In Ayurveda, four Garbha Sambhava Samagri are enumerated as Ritu, Kshetra, Ambu and Beeja. Any abnormalities in any of these affect the formation and development of Garbha.
According to Shabdakalpadhruma, a women who has hindrance of any kind, in the normal process of conception is termed as Vandhya. Infertility according to Ayurveda is not only limited to non-achievement of conception but also includes failure to continue it till viability and birth of a healthy live child. In this Pumbheeja (Shukra) and Streebheeja (Artava) are very much important. [3] Artavanasha is due to Avarana in Artavavaha Srotas. [4] Ashvagandha is mentioned in
A B S T R A C T
Fertility is an existential necessity and as such has assumed over whelming importance from time immemorial. However, not all couples who desire a pregnancy will achieve one spontaneously and a proportion of couples will need medical help to resolve underlying fertility problems. 
MATERIALS AND METHODS
Total 30 women fulfilling the inclusion criteria were selected from outpatient and inpatient department of P.G. Studies in Prasuti Tantra and Stree Roga, S.D.M. College of Ayurveda and Hospital, Hassan in a single group and were studied. The drug Ashvagandha Choorna was obtained from the pharmacy of SDM Centre for Research in Ayurveda and Allied Sciences, Udupi for the present study. The Ethical Clearance for the study was obtained from Institutional ethical committee. The informed and written consent along with specially designed Case Proforma for the study was prepared.
Inclusion Criteria
1. Females of age group of 20 -35 years.
2. Females with normally developed secondary sexual characters, ovary and uterus.
3. Women who are diagnosed with anovulatory cycles and single or multiple cyst in either of the ovaries.
4. Patients who were ready to sign in the informed consent form.
Exclusion Criteria
1. Known case of genetic abnormalities.
Known case of chronic systemic disorders (diabetes mellitus, hypertension, tuberculosis) and endocrinal disorders. (thyroid dysfunction).
Criteria for diagnosis 1. Female patients of primary and secondary infertility were assessed for Anovulation.
2. Anovulation was confirmed by USG -Follicular study.
Drug -Ashvagandha Ksheerapaka (Sharangadhara method 1:4:8 ratio) in a dose 100ml twice a day before food administered Orally.
Duration -Consecutive 3 cycle (from 5th day after cessation of menses till the commencement of next menstrual cycle)
Criteria for Assessment
Sonological Parameters -Follicular study was repeated after completion of oral intake of Ashvagandha Ksheerapaka for three menstrual cycles. Efficacy of therapy was assessed on the basis of size of follicles, endometrial thickness and signs of ovulation.
Patients were divided to following categories for assessment of follicle development and size. 
OBSERVATION
Total 30 subjects registered and all 30 patients completed the study. The data collected from the proforma was subjected to statistical methods using SPSS (version 16) with Friedman's test and Wilcoxon's signed rank test which were filled on the starting of the first day of the treatment. All patients in the present study were having proper development and proper fat distribution on pubis and vulva. Average vaginal discharge was observed in 76.7% of patients, while cervical erosion was found in 13.3% of patients.
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Journal 96.7% of patients were having nulliparous cervix. All of patients were having normal size uterus. 100% of patients had freely mobile uterus and fornices were clear.
After the treatment among 30 patients, in maximum 93.3% there was no change observed in the growth of the follicles, where as in 6.7%, there was slight improvement in follicular growth also the endometrial thickness, but it was not statistically significant. Friedman's test shows that the trial drug is not giving statistically significant result in induction of ovulation. Wilcoxon signed rank test shows that the trial drug is not giving statistically significant result in induction of ovulation.
RESULTS
Among 30 patients maximum 93.3% there was no change observed in the growth of the follicles where as in 6.7% there is slight improvement in follicular growth also the endometrial thickness. But this is not statistically significant.
CONCLUSION
The present work was designed to study the efficacy of Ashvagandha Ksheerapaka in Stree Vandhyatva on anovulation. The effect of Ashvagandha Ksheerapaka is not clinically and statistically significant on ovulation. Better result may be achieved after Shodhana along with the administration of other Prajasthapanagana Dravya or Pumsavana Dravya or other compound medicine. Anyhow, no adverse drug reaction (ADR) and side effects were reported in the present study and the drug in the prescribed dose and the method used for the procedures proved safe.
